OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
52
Results
Show all
Save search
Copy query
Show results for
Unknown
(52)
Publication Date
Release Date
2021
(10)
2022
(8)
2016
(8)
2023
(5)
2020
(4)
2019
(4)
2025
(2)
2024
(2)
2017
(2)
2012
(2)
2018
(1)
2015
(1)
2014
(1)
2013
(1)
2010
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol.
Not available
S-EPMC8502165
|
biostudies-literature
Cite
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Not available
S-EPMC9214580
|
biostudies-literature
Cite
International randomised controlled trial evaluating metabolic syndrome in type 2 diabetic cigarette smokers following switching to combustion-free nicotine delivery systems: the DIASMOKE protocol.
Not available
S-EPMC8088261
|
biostudies-literature
Cite
A scalable and tunable platform for functional interrogation of peptide hormones in fish.
Not available
S-EPMC10597582
|
biostudies-literature
Cite
Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus.
Not available
S-EPMC2945049
|
biostudies-literature
Cite
Nucleolar Reorganization Upon Site-Specific Double-Strand Break Induction.
Not available
S-EPMC5084524
|
biostudies-literature
Cite
Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST
®
T1).
Not available
S-EPMC5248618
|
biostudies-literature
Cite
Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial.
Not available
S-EPMC8991309
|
biostudies-literature
Cite
Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naive Patients with Type 2 Diabetes: A Randomized Controlled Trial.
Not available
S-EPMC5070831
|
biostudies-literature
Cite
Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin.
Not available
S-EPMC7846644
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets